Cdkn1b As A Biomarker - Cancer Science

Relevant Publications

Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes.

Issue Release: 2024

Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma.

Issue Release: 2024

A Genomic Score to Predict Local Control among Patients with Brain Metastases Managed with Radiation.

Issue Release: 2023

Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.

Issue Release: 2022

Hsa_circ_0000437 Inhibits the Development of Endometrial Carcinoma through miR-626/CDKN1B Axis.

Issue Release: 2022

LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer.

Issue Release: 2021

Upregulated Circular RNA hsa_circ_0008433 Regulates Pathogenesis in Endometriosis Via miRNA.

Issue Release: 2020

MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.

Issue Release: 2020

Mislocalized cytoplasmic p27 activates PAK1-mediated metastasis and is a prognostic factor in osteosarcoma.

Issue Release: 2020

Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?

Issue Release: 2020

High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.

Issue Release: 2019

Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells.

Issue Release: 2018

miR-24 regulates CDKN1B/p27 expression in prostate cancer.

Issue Release: 2016

[Basic and translational research progress of gastrointestinal neuroendocrine neoplasmas].

Issue Release: 2016

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Issue Release: 2016

Genome-wide analysis of 5-hmC in the peripheral blood of systemic lupus erythematosus patients using an hMeDIP-chip.

Issue Release: 2015

Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.

Issue Release: 2015

Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.

Issue Release: 2013

Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism.

Issue Release: 2013

CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

Issue Release: 2011

What Treatment Options Does the VA Offer?

What is the impact of HLA typing in cancer immunotherapy?

Why Are Non-Drinking Days Important for Cancer Prevention?

How Does NSF Ensure Product Safety and Compliance?

How Do Oncologists Diagnose Cancer?

Why is Mental Health Support Crucial for Cancer Patients?

How Much Water Should a Cancer Patient Drink?

Can Nutrition Affect Fluid Balance?

How Can HPRD Aid in Identifying Cancer Biomarkers?

What is Pemigatinib?

Partnered Content Networks

Relevant Topics